Alpha V Beta 3 Integrin Aspired Vesicular Nanohybrids Based Neoadjuvant Therapy for Locally Advanced Colon Cancer
Implementing Organization
Principal Investigator
Dr. Aakanchha Jain
National Institute Of Pharmaceutical Education And Research (NIPER) Ahmedabad, Gujarat
About
Neoadjuvant therapy is a treatment used to reduce tumor size or make it easier to remove, used for various types of cancer. Nanomedicine, using nanotechnology, can diagnose, treat, and prevent diseases. In the context of multidrug resistant colon cancer, nanomedicine offers a promising solution by allowing targeted delivery of therapeutic agents directly to the tumor site. The results could impact the field by improving cancer treatment with lesser morbidity, mortality, and metastasis, and potentially reducing the need for surgery. Methodology involved evaluating particle size, surface charge, loading efficiency, particle density, in-vitro drug release, and stability of established vesicular nanohybrids.
Source
Source
Anusandhan National Research Foundation/science and Engineering Research Board (sERB), DsT 2023-24
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Start Year
2023
End Year
2025
Sanction Amount
₹ 31.35 L
Status
Completed
Contact
aakanchha.jain@niperahm.ac.in
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
No. of Patents
Filed :00
Grant :00
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.